|
000
| 02724cam 2200385zi 4500 |
|---|
| 001 | 9.895264 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107173958 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 210113e20200723onc ob f000 0 eng d |
|---|
| 020 | |a9780660371092 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-311/2021E-PDF |
|---|
| 245 | 00|aGuidance document : |bmaster files for veterinary products : procedures and administrative requirements. |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cJuly 23, 2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (29 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : fiches maîtresses pour les produits vétérinaires : procédures et exigences administratives. |
|---|
| 500 | |a"Pub.: 200401." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"The objective of this guidance document is to outline the procedures that veterinary Master File (MF) holders must follow to file confidential business information (CBI) directly with Health Canada's Veterinary Drugs Directorate (VDD) that is cross-referenced in support of an Applicant's veterinary drug submission (including DIN (Drug Identification Number) applications). A MF is a reference document that provides information about specific equipment, processes or components used in the manufacturing, processing, or packaging of a drug. The MF is a useful document for providing CBI to Health Canada that is not available to the manufacturer of the dosage form or to the Applicant of a drug submission. This guidance document provides information on filing requirements, processing and assessment procedures for veterinary MFs, and outlines the registration requirements for administrative changes, updates, withdrawals and closures. It is intended to create greater alignment with the procedures used internationally for the management of MFs"--Introduction, page 6. |
|---|
| 650 | 0|aDrug approval|zCanada. |
|---|
| 650 | 0|aVeterinary drugs|zCanada. |
|---|
| 650 | 0|aVeterinary drug industry|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice : |w(CaOODSP)9.895267 |
|---|
| 856 | 40|qPDF|s586 KB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H164-311-2021-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/veterinary-drugs/legislation-guidelines/guidance-documents/master-files-veterinary-products-procedures-administrative-requirements.html |
|---|